• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺筛查复查:放射科医生的视角。

Breast screening review--a radiologist's perspective.

机构信息

South East London Breast Screening Programme and National Training Centre, Department of Radiology, King's College Hospital, London, UK.

出版信息

Br J Radiol. 2012 Jul;85(1015):845-7. doi: 10.1259/bjr/21332901.

DOI:10.1259/bjr/21332901
PMID:22745202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3474085/
Abstract

Recently published articles in the lay press and scientific journals have questioned the value of breast screening, and have raised concerns about both possible harmful effects and the information provided for females when they receive their screening invitation. A review of data from screening trials and the process for providing information for the public on screening has been announced by Professor Sir Mike Richards, National Clinical Director for Cancer. What are the major issues involved and what expectations should radiologists and other members of the screening team have of the review?

摘要

最近在通俗报刊和科学期刊上发表的一些文章对乳房筛查的价值提出了质疑,并对女性接受筛查邀请时可能产生的有害影响以及提供给她们的信息表示担忧。国家癌症临床主任迈克·理查兹爵士教授宣布对筛查试验数据和为公众提供筛查信息的过程进行审查。所涉及的主要问题是什么,放射科医生和其他筛查小组成员应该对审查有什么期望?

相似文献

1
Breast screening review--a radiologist's perspective.乳腺筛查复查:放射科医生的视角。
Br J Radiol. 2012 Jul;85(1015):845-7. doi: 10.1259/bjr/21332901.
2
Evaluation of the UK breast screening programmes.英国乳房筛查项目评估
Ann Oncol. 2003 Aug;14(8):1206-8. doi: 10.1093/annonc/mdg325.
3
Primary care providers' concerns and recommendations regarding mammography screening for older women.初级保健提供者对老年女性乳房X线筛查的担忧及建议。
J Cancer Educ. 2005 Spring;20(1):34-8. doi: 10.1207/s15430154jce2001_11.
4
Mammography: a radiologist's view.
CA Cancer J Clin. 1979 Jan-Feb;29(1):48-52.
5
National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.美国国立卫生研究院共识发展会议声明:40 - 49岁女性乳腺癌筛查,1997年1月21 - 23日。美国国立卫生研究院共识发展小组。
J Natl Cancer Inst. 1997 Jul 16;89(14):1015-26. doi: 10.1093/jnci/89.14.1015.
6
The planning, execution, and evaluation of a breast cancer detection awareness program.一项乳腺癌检测意识项目的规划、实施与评估。
J Cancer Educ. 1988;3(4):247-55. doi: 10.1080/08858198809527950.
7
[Information on organized screening for breast cancer: qualitative study of women and practitioners in the Poitou-Charentes county].
Sante Publique. 2006 Dec;18(4):533-47. doi: 10.3917/spub.064.0533.
8
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.欧洲乳腺影像学会(EUSOBI)以及来自奥地利、比利时、波斯尼亚和黑塞哥维那、保加利亚、克罗地亚、捷克共和国、丹麦、爱沙尼亚、芬兰、法国、德国、希腊、匈牙利、冰岛、爱尔兰、意大利、以色列、立陶宛、摩尔多瓦、荷兰、挪威、波兰、葡萄牙、罗马尼亚、塞尔维亚、斯洛伐克、西班牙、瑞典、瑞士和土耳其的30个国家乳腺放射学机构关于乳腺癌筛查的立场文件
Eur Radiol. 2017 Jul;27(7):2737-2743. doi: 10.1007/s00330-016-4612-z. Epub 2016 Nov 2.
9
The surgeon's role in breast screening.外科医生在乳房筛查中的作用。
World J Surg. 1989 Jan-Feb;13(1):19-24. doi: 10.1007/BF01671149.
10
The war against skin cancer: the time for action is now.对抗皮肤癌之战:行动之时就在当下。
Arch Dermatol. 2005 Apr;141(4):499-501. doi: 10.1001/archderm.141.4.499.

引用本文的文献

1
Predicting Ki-67 expression levels in breast cancer using radiomics-based approaches on digital breast tomosynthesis and ultrasound.使用基于放射组学的方法在数字化乳腺断层合成和超声上预测乳腺癌中的Ki-67表达水平。
Front Oncol. 2024 Jul 11;14:1403522. doi: 10.3389/fonc.2024.1403522. eCollection 2024.
2
Detection and diagnosis of automated breast ultrasound in patients with BI-RADS category 4 microcalcifications: a retrospective study.BI-RADS 4 类微钙化患者自动乳腺超声检测与诊断:一项回顾性研究。
BMC Med Imaging. 2024 May 28;24(1):126. doi: 10.1186/s12880-024-01287-4.
3
Exploiting Patch Sizes and Resolutions for Multi-Scale Deep Learning in Mammogram Image Classification.利用补丁大小和分辨率进行乳腺X光图像分类中的多尺度深度学习
Bioengineering (Basel). 2023 Apr 27;10(5):534. doi: 10.3390/bioengineering10050534.
4
Intra- and peri-tumoral radiomics for predicting the sentinel lymph node metastasis in breast cancer based on preoperative mammography and MRI.基于术前乳腺钼靶和MRI的瘤内及瘤周放射组学预测乳腺癌前哨淋巴结转移
Front Oncol. 2022 Dec 12;12:1047572. doi: 10.3389/fonc.2022.1047572. eCollection 2022.
5
Digital breast tomosynthesis-based peritumoral radiomics approaches in the differentiation of benign and malignant breast lesions.基于数字乳腺断层合成的肿瘤周围放射组学方法在鉴别良恶性乳腺病变中的应用。
Diagn Interv Radiol. 2022 May;28(3):217-225. doi: 10.5152/dir.2022.20664.
6
Radiomic Evaluations of the Diagnostic Performance of DM, DBT, DCE MRI, DWI, and Their Combination for the Diagnosisof Breast Cancer.数字乳腺摄影(DM)、数字乳腺断层摄影(DBT)、动态对比增强磁共振成像(DCE MRI)、扩散加权成像(DWI)及其联合应用对乳腺癌诊断性能的影像组学评估
Front Oncol. 2021 Sep 10;11:725922. doi: 10.3389/fonc.2021.725922. eCollection 2021.
7
Can the synthetic C view images be used in isolation for diagnosing breast malignancy without reviewing the entire digital breast tomosynthesis data set?合成C视图图像能否在不查看整个数字乳腺断层合成数据集的情况下单独用于诊断乳腺恶性肿瘤?
Ir J Med Sci. 2018 Nov;187(4):1077-1081. doi: 10.1007/s11845-018-1748-7. Epub 2018 Feb 9.
8
Is the false-positive rate in mammography in North America too high?北美乳房X光检查的假阳性率是否过高?
Br J Radiol. 2016 Sep;89(1065):20160045. doi: 10.1259/bjr.20160045. Epub 2016 Jun 8.

本文引用的文献

1
Benefits and harms of mammography screening.乳腺钼靶筛查的益处与危害。
BMJ. 2012 Jan 6;344:d8279. doi: 10.1136/bmj.d8279.
2
Possible net harms of breast cancer screening: updated modelling of Forrest report.乳腺癌筛查的潜在净危害:福雷斯特报告的更新建模。
BMJ. 2011 Dec 8;343:d7627. doi: 10.1136/bmj.d7627.
3
The NHS breast screening programme needs independent review.英国国家医疗服务体系(NHS)的乳房筛查计划需要独立审查。
BMJ. 2011 Oct 25;343:d6894. doi: 10.1136/bmj.d6894.
4
An independent review is under way.正在进行独立审查。
BMJ. 2011 Oct 25;343:d6843. doi: 10.1136/bmj.d6843.
5
The breast screening programme and misinforming the public.乳腺筛查项目与误导公众
J R Soc Med. 2011 Sep;104(9):361-9. doi: 10.1258/jrsm.2011.110078.
6
Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization.在英格兰扩大乳腺癌筛查年龄范围:评估随机分组可行性和可接受性的试点研究。
J Med Screen. 2011;18(2):96-102. doi: 10.1258/jms.2011.011065.
7
Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality?考虑到乳腺钼靶筛查存在大量过度诊断率且对死亡率影响较小,这种筛查是否合理?
Radiology. 2011 Sep;260(3):621-7. doi: 10.1148/radiol.11110210.
8
Mammographic screening and "overdiagnosis".乳房X光筛查与“过度诊断”
Radiology. 2011 Sep;260(3):616-20. doi: 10.1148/radiol.11110716.
9
Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.不同筛查水平但治疗可及性相似的欧洲邻国的乳腺癌死亡率:世卫组织死亡率数据库的趋势分析。
BMJ. 2011 Jul 28;343:d4411. doi: 10.1136/bmj.d4411.
10
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.瑞典两县试验:30 年来乳腺 X 线筛查对乳腺癌死亡率的影响。
Radiology. 2011 Sep;260(3):658-63. doi: 10.1148/radiol.11110469. Epub 2011 Jun 28.